Also, if you are diagnosed of renal conditions, your caregiving team must stay aware of such problems
There are two main MTHFR mutations the C677T and the A1298C mutation
In the SUSTAIN clinical trial program evaluating injectable semaglutide for type 2 diabetes, the 1 mg weekly dose reduced HbA1c by approximately 1.41.6% from baseline, while the SUSTAIN FORTE trial showed that the 2 mg dose provided additional glycemic benefits for patients needing intensification
GLP-1 is also believed to participate in weight loss after bariatric surgery which brings food more rapidly into the distal small intestine
However, clinical observations and trial data have identified specific circumstances where these drugs may be associated with worsening diabetic retinopathy, particularly in patients with pre-existing retinal disease
The next generation of GLP1 medicationsespecially oral versions and longer-acting injectablesis expected to improve access and make it easier for people to stay on the treatment (37)